查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
家禽药品市场按动物类型、产品、疾病类型、给药途径和地区划分 - 预测至 2029 年
市场调查报告书
商品编码
1647383

家禽药品市场按动物类型、产品、疾病类型、给药途径和地区划分 - 预测至 2029 年

Poultry Medicine/Pharmaceuticals Market by Animal Type, Product, Disease Indication, Route of Administration - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 425 Pages | 订单完成后即时交付

价格

家禽药物市场规模预计将从 2024 年的 50.1 亿美元增至 2029 年的 66.8 亿美元，预测期内的复合年增长率为 5.9%。

新兴国家家禽及其产品消费量的增加，导致家禽饲养方法的增加，这是家禽药品市场成长的主要原因。家禽疾病（尤其是新城疫和球虫）的增加导致了对疫苗、抗生素和免疫增强剂的需求。此外，人们对食品安全的日益关注以及抗生素使用的减少，导致许多家禽养殖场转向益生菌和更有效的疫苗等替代疗法。此外，开发中国家家禽生产率的提高也增加了对有助于永续、安全和高产家禽养殖的有效药物的需求。

研究范围
调查年份 2024-2029
基准年 2023
预测期 2024-2029
考虑单位 金额（美元）
部分 依动物类型、产品、疾病类型、给药途径及地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

根据动物类型，鸡肉预计将占据家禽药品市场最大的市场占有率。这是因为家禽对鸡肉和鸡蛋等蛋白质来源的消费量很高。需求的增加导致了鸡肉产量的增加，特别是在开发中地区，并改变了家禽养殖的时代。鸡也容易感染几种疾病，包括新城疫、传染性支气管炎和球虫。这解释了使用疫苗、抗生素和益生菌来改善羊群健康和生产力的原因。卵内接种等疫苗接种方法的创新正在提高大规模疫苗接种的效率和有效性，并为家禽药物的消费提供更多途径。

根据产品类型，疫苗占据了市场的最大份额，因为它们对于预防新城疫、传染性支气管炎和禽流感等在大型畜群中迅速传播的传染病至关重要。有效地对家禽进行疫苗接种可确保家禽健康和生产力，并最大限度地减少因兽医当局最终下令扑杀家禽而造成的损失。减少抗生素使用的监管压力使得疫苗成为控制疾病的首选，因为它们可以在不增加抗生素抗药性的情况下预防感染。卵疫苗接种等技术进步实现了高效的大规模疫苗接种，使疫苗接种对于大型家禽养殖场实用且可扩展。在疾病预防和永续养殖实践方面，疫苗已巩固了其作为家禽药品市场最大细分市场的地位。

该市场的最大份额是新城疫，因为该疾病影响全球家禽并对家禽养殖户造成严重的经济影响。由于疫情造成的高死亡率和严重的生产力损失，疫苗接种计划是必要的。因此，针对新城疫的疫苗对于家禽健康管理至关重要。第二代重组耐热疫苗有助于提高易用性，并在实施集约化家禽养殖的国家使用。随着对疾病预防和政府控制计画的持续重视，新城疫已成为家禽药物市场最大的类别。

根据给药途径，与其他途径相比，家禽药物的口服给药途径在大群给药中高效且方便，因为它可以通过水或饲料输送药物，从而向所有鸟类提供相同剂量，而无需对单个鸟类进行耗时和紧张的处理。口服给药最适合抗生素、疫苗、益生菌和维生素，因此可用于各种预防和治疗方法。降低劳动力成本、简化剂量和在大规模家禽系统中使用（其中快速有效地控制疾病至关重要）使得这种方法非常受欢迎。鑑于口服给药的实用性和规模经济性，这种方法成为了家禽养殖业务的支柱，并占据了製药/药品市场的主导地位。

本报告研究了全球家禽药品市场，并提供了按动物类型、产品类型、疾病类型、给药途径、区域趋势和公司概况分類的市场详细资讯。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 产业趋势
  • 价值链分析
  • 供应链分析
  • 技术分析
  • 波特五力分析
  • 监管状态
  • 专利分析
  • 贸易分析
  • 定价分析
  • 2024-2025 年的重要会议与活动
  • 主要相关人员和采购标准
  • 未满足的需求和最终用户的期望
  • 生态系市场分析
  • 案例研究分析
  • 邻近市场分析
  • 投资金筹措场景
  • 人工智慧/生成式人工智慧对家禽药物市场的影响

6. 家禽药物市场（依动物类型）

  • 介绍
  • 鸡
  • 火鸡
  • 鸭子
  • 其他的

7. 家禽药物市场（依产品）

  • 介绍
  • 药物
  • 疫苗
  • 饲料添加剂

8. 家禽药物市场（依疾病类型）

  • 介绍
  • 新城疫
  • 传染性支气管炎
  • 传染性法氏囊病
  • 球虫
  • 沙门氏菌
  • 马立克氏症
  • 其他的

9. 禽用药物市场（依给药途径）

  • 介绍
  • 口服
  • 单独注射给药
  • 局部给药
  • 其他的

第 10 章 禽用药物市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十一章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 品牌/产品比较
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • MERCK ANIMAL HEALTH（SUBSIDIARY OF MERCK & CO., INC.）
    • ELANCO
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • CEVA SANTE ANIMALE
    • ZOETIS SERVICES LLC
    • VIRBAC
    • PHIBRO ANIMAL HEALTH CORPORATION
    • HESTER BIOSCIENCES LIMITED
    • MEIJI ANIMAL HEALTH CO, LTD.（SUBSIDIARY OF KM BIOLOGICS CO. LTD.）
    • VENKY'S INDIA
    • BIMEDA CORPORATE
    • CALIER
    • HIPRA
    • VETANCO
    • VAXXINOVA INTERNATIONAL BV
    • BIOVAC GROUP
    • KEMIN INDUSTRIES, INC.
    • OLKAR.-AGROZOOVET-SERVICE
    • INDOVAX
    • AVIMEX
  • 其他公司
    • SYNTHESE ELEVAGE
    • PROVET PHARMA PRIVATE LIMITED
    • HUVEPHARMA
    • ROMVAC COMPANY SA
    • VMN PHARMACEUTICALS

第十三章 附录

Product Code: MD 9278

The poultry medicine/pharmaceuticals market is projected to reach USD 6.68 billion by 2029 from USD 5.01 billion in 2024, at a CAGR of 5.9% during the forecast period. The increasing consumption of poultry and its products from the developing countries is mainly responsible for the growth of poultry medicine/pharmaceuticals market as it results in increased poultry farming practices. The rise in illnesses in poultry, especially Newcastle disease and Coccidiosis, leads to the need for vaccines, antibiotics, and immune boosters. Also, the growing attention towards food safety and the reduction of antibiotics, has made many farms to resort to alternative therapies such as probiotics and more effective vaccines. Furthermore, the growing rates of poultry production amongst developing countries increases the demand for efficacious medicine/pharmaceuticals, which contributes to the sustainable, safe and productive poultry keeping.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsAnimal Type, Product, Disease Indication, Route of Administration, and Region
Regions coveredNorth America, Europe, APAC, LATAM, and MEA (GCC Countries, RoMEA)

"By animal type, chickens segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on animal type, the chickens segment is expected to hold the largest market share in the poultry medicine/pharmaceuticals market. Owing to high domestic poultry consumption of protein sources like chicken meat and eggs. This increase in demand has contributed change in age to the poultry farming especially in developing areas with an increase in the production of chickens. Chickens are also commonly affected by several diseases; Newcastle disease, Infectious Bronchitis and Coccidiosis, which explains the use of vaccines, antibiotics and probiotics to enhance the health and productivity of the flocks Several factors attributed to increasing food production also explain the need for higher standards biologically and on farm bio-security interventions. Innovations in vaccine delivery methods such as in ovo vaccination have enhanced the efficiency and effectiveness of immunization on a large scale providing more avenues for consumption of poultry medicine/pharmaceuticals.

"By product, vaccine segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on product, the largest share of this market is vaccines since they are critical in the prevention of infectious diseases which can rapidly spread through large flocks, like Newcastle disease, Infectious Bronchitis, and Avian Influenza. Effective vaccination of a poultry flock ensures health, productivity, and minimization of losses due to eventual flock culling order by the veterinary authority. Regulatory pressure to lower the use of antibiotics makes vaccines a preferred choice in the management of diseases as they prevent infections without adding to antimicrobial resistance. Technology advancement, such as ovo vaccination, allows for efficient mass immunization; thus, vaccine administration has become practical and scalable to large poultry farms. In the context of disease prevention and sustainable farming practices, vaccines have cemented their position as the largest segment in the poultry medicine/pharmaceuticals market.

"By disease indication, newcastle disease segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on disease indication, the largest share of this market is newcastle disease since the disease affects the poultry worldwide and severely impacts poultry farmers economically. High mortality rates and losses in productivity due to outbreak required vaccination programmes; therefore, vaccines against Newcastle disease are indispensable in poultry health management. Second-generation recombinant and thermostable vaccines have helped increase the ease of use and thus their usage in countries with intensive poultry farming. The continued emphasis on disease prevention and government containment programs have made Newcastle Disease the largest category in the poultry medicine/pharmaceuticals market.

"By route of administration, oral segment is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

Based on route of administration, The oral route of administration in poultry medicine/pharmaceuticals is efficient and convenient in the medication of large flocks in comparison to the other routes as it delivers medication through either water or feed, thereby getting an equal amount of dose delivery to all birds without time-consuming and stressful individual birds' handling. The oral route is most suited for antibiotics, vaccines, probiotics, and vitamins and therefore used in a very diversified preventive and therapeutic mode of application. Labor cost-cutting, simplification in dosing, and accommodation in large-scale poultry systems where quick effective management of disease is important make this route highly acceptable. Given the practicality and economies of scale involved in oral delivery, this mode forms the mainstay in the poultry farming business and commands the market for medicine/pharmaceuticals.

"By region, North America region is expected to have the largest market share in the poultry medicine/pharmaceuticals market."

The poultry medicine/pharmaceuticals market is dominated by North America as a result of advanced poultry farming systems prevalent in the region, high poultry products intake, and greater concern for biosecurity and disease control. The region is characterized by existing legislation that encourages responsible antibiotic use and as a consequence drive producers to vaccines and other health solutions in the production of food. Continuous investments in research and development as well as modern technologies put in place for the management and therapy of diseases further promotes upward movement of this market. On top of that, due to the fact that there is a growing need for sustainable as well as high-yield systems of poultry rearing, the production of medicines that assist in maintaining flocks health and productivity has increased in the region thereby further entrenching North America's market leader position.

A breakdown of the primary participants (supply-side) for the poultry medicine/pharmaceuticals market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
  • By Designation: C-level-20%, Director Level-35%, and Others-45%
  • By Region: North America-27%, Europe-25%, Asia Pacific-30%, ROW-18%

Prominent players in the poultry medicine/pharmaceuticals market are are MSD (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Zoetis Service LLC (US), Virbac (France), Phibro Animal Health (US), Hester Biosciences Limited (India), Meiji Animal Health (Japan), Venky's India (India), Bimeda Corporate (Ireland), Calier (Spain), Hipra (Spain), Vetanco (Argentina), Vaxxinova (Netherlands), Biovac Group (Israel), Kemin Industries (US), O.L.KAR Agrozoovet Service (Ukraine), Indovax (India), Avimex (Mexico), Synthese Elevage (France), Provet Pharma Pvt Ltd (India), Huvepharma (Bulgaria), Romvac Company (Romania), and VMN Pharmaceuticals (Turkey).

Research Coverage:

The report analyzes the poultry medicine/pharmaceuticals market and aims at estimating the market size and future growth potential of this market based on various segments such as animal type, product, route of administration and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall poultry medicine/pharmaceuticals market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing poultry consumption, growing incidence of poultry diseases, advances in poultry medicine/pharmaceuticals, initiatives by government agencies and animal associations), restraints (high cost of vaccines development, antibiotic resistance concerns), opportunities (growth in emerging markets, industrialization of poultry farming), challenges (regulatory compliance)
  • ZMarket Penetration: It includes extensive information on products offered by the major players in the global the poultry medicine/pharmaceuticals market. The report includes various segments in offering, application, end user and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global poultry medicine/pharmaceuticals market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the poultry medicine/pharmaceuticals market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global poultry medicine/pharmaceuticals market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKETS & REGIONS COVERED
    • 1.3.1 YEARS CONSIDERED
    • 1.3.2 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 POULTRY PHARMACEUTICALS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT AND COUNTRY (2023)
  • 4.3 POULTRY PHARMACEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 POULTRY PHARMACEUTICALS MARKET, BY REGION (2022-2029)
  • 4.5 POULTRY PHARMACEUTICALS MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing poultry consumption
      • 5.2.1.2 Growing incidence of poultry diseases
      • 5.2.1.3 Advancements in poultry pharmaceuticals
      • 5.2.1.4 Favorable initiatives by government agencies & animal welfare associations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of vaccine development
      • 5.2.2.2 Concerns associated with antibiotic resistance
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth potential of emerging economies
      • 5.2.3.2 Industrialization of poultry farming
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory compliance for poultry pharmaceuticals
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ANTIBIOTIC-FREE SOLUTIONS
    • 5.3.2 EMERGENCE OF INNOVATIVE VACCINE TECHNOLOGIES
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 mRNA vaccines
      • 5.6.1.2 Nanoparticle drug delivery
      • 5.6.1.3 CRISPR gene editing
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 IoT-enabled health monitoring
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 Automated drug delivery systems
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY LANDSCAPE
    • 5.8.1 REGULATORY ANALYSIS
      • 5.8.1.1 US
      • 5.8.1.2 Europe
      • 5.8.1.3 Asia Pacific
      • 5.8.1.4 Latin America
      • 5.8.1.5 Middle East & Africa
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.8.2.1 North America
      • 5.8.2.2 Europe
      • 5.8.2.3 Rest of the World
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR POULTRY PHARMACEUTICALS
  • 5.10 TRADE ANALYSIS
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICALS, BY REGION (2022-2024)
    • 5.11.2 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023)
  • 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 UNMET NEEDS AND END-USER EXPECTATIONS
    • 5.14.1 UNMET NEEDS
    • 5.14.2 END-USER EXPECTATIONS
  • 5.15 ECOSYSTEM MARKET ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: MARKET DEVELOPMENT IN NIGER DELTA (MADE)
    • 5.16.2 CASE STUDY 2: JOURNEY OF TRIBAL WOMEN
    • 5.16.3 CASE STUDY 3: PROBLEMS & PROSPECTS OF POULTRY FARMING IN CHITTOOR, ANDHRA PRADESH
  • 5.17 ADJACENT MARKET ANALYSIS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI/GENAI ON POULTRY PHARMACEUTICALS MARKET

6 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE

  • 6.1 INTRODUCTION
  • 6.2 CHICKEN
    • 6.2.1 BROILER
      • 6.2.1.1 Specifically bred for high meat yield to drive market
    • 6.2.2 LAYER
      • 6.2.2.1 Growing demand for eggs to fuel market
  • 6.3 TURKEY
    • 6.3.1 CONSUMER PREFERENCE FOR ORGANIC TURKEY BY-PRODUCTS TO DRIVE MARKET
  • 6.4 DUCK
    • 6.4.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED VACCINES FOR DVH TO FUEL UPTAKE
  • 6.5 OTHER POULTRY

7 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 DRUGS
    • 7.2.1 ANTIBIOTICS
      • 7.2.1.1 Most widely used drug in poultry management to drive market
    • 7.2.2 ANTIPARASITICS
      • 7.2.2.1 Ability to combat against coccidiosis and ectoparasites to boost demand
    • 7.2.3 ANTISEPTICS
      • 7.2.3.1 Maintainance of biosecurity through infection reduction to fuel uptake
    • 7.2.4 NUTRITIONALS
      • 7.2.4.1 Optimization of poultry health with enhanced productivity to support market growth
    • 7.2.5 OTHER DRUGS
  • 7.3 VACCINES
    • 7.3.1 LIVE-ATTENUATED VACCINES
      • 7.3.1.1 Cost-efficiency and high efficacy benefits to fuel uptake
    • 7.3.2 INACTIVATED VACCINES
      • 7.3.2.1 Pathogen carriers with high stability to drive market
    • 7.3.3 RECOMBINANT VACCINES
      • 7.3.3.1 Ability to combat several avian diseases to boost demand
    • 7.3.4 OTHER VACCINES
  • 7.4 FEED ADDITIVES
    • 7.4.1 ADDITIONAL INCORPORATION TO DIETS FOR ENHANCED BENEFITS TO SUPPORT MARKET GROWTH

8 POULTRY PHARMACEUTICALS MARKET, BY DISEASE TYPE

  • 8.1 INTRODUCTION
  • 8.2 NEWCASTLE DISEASE
    • 8.2.1 INNOVATIONS IN NEXT-GEN VACCINES TO PROPEL MARKET
  • 8.3 INFECTIOUS BRONCHITIS
    • 8.3.1 HIGH MORTALITY CASES TO BOOST DEMAND
  • 8.4 INFECTIOUS BURSAL DISEASE
    • 8.4.1 GROWING DEMAND FOR MULTIVALENT VACCINES TO FUEL MARKET
  • 8.5 COCCIDIOSIS
    • 8.5.1 DEVELOPMENT OF ANTI-COCCIDIAL DRUGS TO FUEL UPTAKE
  • 8.6 SALMONELLA
    • 8.6.1 INCREASING INCIDENCE OF SALMONELLA OUTBREAKS TO DRIVE MARKET
  • 8.7 MAREK'S DISEASE
    • 8.7.1 GROWING FOCUS ON ENSURING FLOCK PRODUCTIVITY TO SUPPORT MARKET
  • 8.8 OTHER DISEASES

9 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

  • 9.1 INTRODUCTION
  • 9.2 ORAL ROUTE OF ADMINISTRATION
    • 9.2.1 HIGH UPTAKE OF ANTIBIOTICS DUE TO SCALABILITY AND COST-EFFICIENCY TO DRIVE MARKET
  • 9.3 INJECTABLE ROUTE OF ADMINISTRATION
    • 9.3.1 RAPID TREATMENT RESPONSE TO FUEL MARKET
  • 9.4 TOPICAL ROUTE OF ADMINISTRATION
    • 9.4.1 UPTAKE OF ANTIPARASITIC TREATMENT TO SUPPORT MARKET GROWTH
  • 9.5 OTHER ROUTES

10 POULTRY PHARMACEUTICALS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Stringent regulatory protocols for disease prevention to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Growing focus on animal health to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Growing awareness of poultry health issues in Germany
    • 10.3.3 UK
      • 10.3.3.1 Growing focus on antibiotic-free poultry to boost demand
    • 10.3.4 FRANCE
      • 10.3.4.1 Avian influenza outbreaks and disease prevention strategies to fuel market growth
    • 10.3.5 SPAIN
      • 10.3.5.1 Increased poultry production and export to drive market
    • 10.3.6 ITALY
      • 10.3.6.1 Rising poultry trade and biosecurity measures to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Focus on biosecurity and innovative pharmaceutical products to drive market
    • 10.4.3 CHINA
      • 10.4.3.1 Increasing incidence of avian influenza to boost demand
    • 10.4.4 INDIA
      • 10.4.4.1 Rapid expansion of poultry farming to fuel uptake
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Growing focus on advanced pharmaceuticals to support market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Frequent outbreak of coccidiosis to support market growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Surge in poultry export to fuel uptake
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing investments in broiler genetics to propel market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Expanding poultry sector to fuel uptake
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POULTRY PHARMACEUTICALS MARKET
  • 11.3 REVENUE ANALYSIS, 2019-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Animal type footprint
      • 11.5.5.4 Product footprint
      • 11.5.5.5 Disease indication footprint
      • 11.5.5.6 Route of administration footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS
    • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 MERCK ANIMAL HEALTH (SUBSIDIARY OF MERCK & CO., INC.)
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 MnM view
        • 12.1.1.3.1 Key strengths
        • 12.1.1.3.2 Strategic choices
        • 12.1.1.3.3 Weaknesses & competitive threats
    • 12.1.2 ELANCO
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
        • 12.1.2.3.2 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product approvals
        • 12.1.3.3.2 Deals
        • 12.1.3.3.3 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 CEVA SANTE ANIMALE
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Key strengths
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses & competitive threats
    • 12.1.5 ZOETIS SERVICES LLC
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
        • 12.1.5.3.2 Expansions
        • 12.1.5.3.3 Other developments
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 VIRBAC
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Deals
    • 12.1.7 PHIBRO ANIMAL HEALTH CORPORATION
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 HESTER BIOSCIENCES LIMITED
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 MEIJI ANIMAL HEALTH CO, LTD. (SUBSIDIARY OF K.M BIOLOGICS CO. LTD.)
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 VENKY'S INDIA
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 BIMEDA CORPORATE
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 CALIER
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 HIPRA
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 VETANCO
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 VAXXINOVA INTERNATIONAL BV
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
    • 12.1.16 BIOVAC GROUP
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
    • 12.1.17 KEMIN INDUSTRIES, INC.
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products offered
    • 12.1.18 O.L.KAR.-AGROZOOVET-SERVICE
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products offered
    • 12.1.19 INDOVAX
      • 12.1.19.1 Business overview
      • 12.1.19.2 Products offered
    • 12.1.20 AVIMEX
      • 12.1.20.1 Business overview
      • 12.1.20.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 SYNTHESE ELEVAGE
    • 12.2.2 PROVET PHARMA PRIVATE LIMITED
    • 12.2.3 HUVEPHARMA
    • 12.2.4 ROMVAC COMPANY S.A.
    • 12.2.5 VMN PHARMACEUTICALS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 POULTRY PHARMACEUTICALS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 IMPACT ANALYSIS OF PORTER'S FIVE FORCES
  • TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 LIST OF PATENTS IN POULTRY PHARMACEUTICALS MARKET, 2022-2024
  • TABLE 8 IMPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES (HS CODE 300490), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF POULTRY PHARMACEUTICAL PRODUCTS, BY REGION (2022-2024)
  • TABLE 11 AVERAGE SELLING PRICE OF POULTRY VACCINES, BY KEY PLAYER (2023) (USD)
  • TABLE 12 POULTRY PHARMACEUTICALS MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 14 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 15 END-USER EXPECTATIONS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • TABLE 16 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM ANALYSIS
  • TABLE 17 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 18 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 19 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 20 CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 21 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 22 CHICKEN PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 23 BROILER PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 24 BROILER PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 25 LAYER PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 26 LAYER PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 27 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 28 TURKEY PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 29 DUCK PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 30 DUCK PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 31 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 32 OTHER POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 33 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 34 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 35 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 36 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 37 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 38 POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 39 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 40 POULTRY PHARMACEUTICALS MARKET FOR ANTIBIOTICS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 41 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 42 POULTRY PHARMACEUTICALS MARKET FOR ANTIPARASITICS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 43 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 44 POULTRY PHARMACEUTICALS MARKET FOR ANTISEPTICS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 45 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 46 POULTRY PHARMACEUTICALS MARKET FOR NUTRITIONALS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 47 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 48 POULTRY PHARMACEUTICALS MARKET FOR OTHER DRUGS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 49 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 50 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 51 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 52 POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 53 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 54 POULTRY PHARMACEUTICALS MARKET FOR LIVE-ATTENUATED VACCINES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 55 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 56 POULTRY PHARMACEUTICALS MARKET FOR INACTIVATED VACCINES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 57 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 58 POULTRY PHARMACEUTICALS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 59 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 60 POULTRY PHARMACEUTICALS MARKET FOR OTHER VACCINES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 61 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 62 POULTRY PHARMACEUTICALS MARKET FOR FEED ADDITIVES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 63 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 64 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 65 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 66 POULTRY PHARMACEUTICALS MARKET FOR NEWCASTLE DISEASE, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 67 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 68 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 69 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 70 POULTRY PHARMACEUTICALS MARKET FOR INFECTIOUS BURSAL DISEASE, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 71 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 72 POULTRY PHARMACEUTICALS MARKET FOR COCCIDIOSIS, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 73 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 74 POULTRY PHARMACEUTICALS MARKET FOR SALMONELLA, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 75 POULTRY PHARMACEUTICALS MARKET FOR MAREK'S DISEASE, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 76 POULTRY PHARMACEUTICALS MARKET FOR MAREK'S DISEASE, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 77 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 78 POULTRY PHARMACEUTICALS MARKET FOR OTHER DISEASES, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 79 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 80 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 81 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 82 ORAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 83 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 84 INJECTABLE ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 85 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 86 TOPICAL ROUTE OF ADMINISTRATION MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 87 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 88 OTHER ROUTES OF ADMINISTRATION MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 89 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 90 POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 92 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 94 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 96 NORTH AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 98 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 100 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 102 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 104 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 106 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 107 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 108 US: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 109 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 110 US: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 111 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 112 US: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 113 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2019-2022 (USD MILLION)
  • TABLE 114 US: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2023-2029 (USD MILLION)
  • TABLE 115 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 116 US: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 117 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 118 US: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 119 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 120 US: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 121 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 122 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 123 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 124 CANADA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 125 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 126 CANADA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 127 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 128 CANADA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 129 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 130 CANADA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 131 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 132 CANADA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 133 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 134 CANADA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 135 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 136 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 137 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 138 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 139 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 140 EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 141 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 142 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 143 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 144 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 145 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 146 EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 147 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 148 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 149 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 150 EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 151 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 152 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 153 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 154 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 155 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 156 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 157 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2019-2022 (USD MILLION)
  • TABLE 158 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE 2023-2029 (USD MILLION)
  • TABLE 159 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 160 GERMANY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 161 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 162 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 163 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 164 GERMANY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 165 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 166 UK: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 167 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 168 UK: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 169 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 170 UK: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 171 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 172 UK: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 173 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 174 UK: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 175 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 176 UK: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 177 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 178 UK: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 179 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 180 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 181 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 182 FRANCE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 183 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 184 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 185 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 186 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 187 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 188 FRANCE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 189 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 190 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 191 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 192 FRANCE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 193 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 194 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 195 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 196 SPAIN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 197 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 198 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 199 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 200 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 201 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 202 SPAIN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 203 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 204 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 205 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 206 SPAIN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 207 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 208 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 209 ITALY: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 210 ITALY: CHICEKN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 211 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 212 ITALY: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 213 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 214 ITALY: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 215 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 216 ITALY: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 217 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 218 ITALY: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 219 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 220 ITALY: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 221 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 222 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 223 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 224 REST OF EUROPE: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 225 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 226 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 227 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 228 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 229 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 230 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 232 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 234 REST OF EUROPE: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 251 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 252 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 253 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 254 JAPAN: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 255 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 256 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 257 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 258 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 259 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 260 JAPAN: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 261 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 262 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 263 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 264 JAPAN: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 265 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 266 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 267 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 268 CHINA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 269 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 270 CHINA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 271 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 272 CHINA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 273 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 274 CHINA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 275 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 276 CHINA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 277 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 278 CHINA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 279 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 280 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 281 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 282 INDIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 283 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 284 INDIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 285 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 286 INDIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 287 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 288 INDIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 289 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 290 INDIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 291 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 292 INDIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 293 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 294 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 295 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 296 AUSTRALIA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 297 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 298 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 299 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 300 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 301 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 302 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 303 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 304 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 305 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 306 AUSTRALIA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 307 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 308 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 309 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 310 SOUTH KOREA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 311 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 312 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 313 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 314 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 315 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 316 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 317 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 318 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 319 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 320 SOUTH KOREA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 321 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 322 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 323 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 324 REST OF ASIA PACIFIC: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 325 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 326 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 327 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 328 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 329 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 330 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 331 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 332 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 333 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 334 REST OF ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 335 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
  • TABLE 336 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 338 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 339 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 340 LATIN AMERICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 341 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 342 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 343 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 344 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 346 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 348 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 349 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 350 LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 351 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 352 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 353 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 354 BRAZIL: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 355 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 356 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 357 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 358 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 359 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 360 BRAZIL: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 361 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 362 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 363 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 364 BRAZIL: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 365 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 366 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 367 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 368 MEXICO: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 369 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 370 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 371 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 372 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 373 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 374 MEXICO: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 375 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 376 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 377 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 378 MEXICO: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR CHICKEN, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 384 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 385 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 386 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 387 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 388 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 389 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 390 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 391 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 392 REST OF LATIN AMERICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 393 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2019-2022 (USD MILLION)
  • TABLE 394 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY REGION, 2023-2029 (USD MILLION)
  • TABLE 395 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 396 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 397 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 398 MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 399 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 400 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 401 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 402 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 403 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 404 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 406 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 409 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 410 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 411 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 412 GCC COUNTRIES: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 413 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 414 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 416 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 419 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 423 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2019-2022 (USD MILLION)
  • TABLE 424 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2023-2029 (USD MILLION)
  • TABLE 425 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 426 REST OF MIDDLE EAST & AFRICA: CHICKEN PHARMACEUTICALS MARKET, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 427 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2019-2022 (USD MILLION)
  • TABLE 428 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2023-2029 (USD MILLION)
  • TABLE 429 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 430 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR DRUGS, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 431 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2019-2022 (USD MILLION)
  • TABLE 432 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET FOR VACCINES, BY TYPE, 2023-2029 (USD MILLION)
  • TABLE 433 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2019-2022 (USD MILLION)
  • TABLE 434 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2023-2029 (USD MILLION)
  • TABLE 435 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2022 (USD MILLION)
  • TABLE 436 REST OF MIDDLE EAST & AFRICA: POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2029 (USD MILLION)
  • TABLE 437 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 438 POULTRY PHARMACEUTICALS MARKET: DEGREE OF COMPETITION
  • TABLE 439 POULTRY PHARMACEUTICALS MARKET: REGION FOOTPRINT
  • TABLE 440 POULTRY PHARMACEUTICALS MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 441 POULTRY PHARMACEUTICALS MARKET: PRODUCT FOOTPRINT
  • TABLE 442 POULTRY PHARMACEUTICALS MARKET: DISEASE INDICATION FOOTPRINT
  • TABLE 443 POULTRY PHARMACEUTICALS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
  • TABLE 444 POULTRY PHARMACEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 445 POULTRY PHARMACEUTICALS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 446 POULTRY PHARMACEUTICALS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 447 POULTRY PHARMACEUTICALS MARKET: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 448 POULTRY PHARMACEUTICALS MARKET: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 449 POULTRY PHARMACEUTICALS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
  • TABLE 450 MERCK ANIMAL HEALTH: COMPANY OVERVIEW
  • TABLE 451 MERCK ANIMAL HEALTH: PRODUCTS OFFERED
  • TABLE 452 ELANCO: COMPANY OVERVIEW
  • TABLE 453 ELANCO: PRODUCTS OFFERED
  • TABLE 454 ELANCO: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 455 ELANCO: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 456 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 457 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 458 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021- NOVEMBER 2024
  • TABLE 459 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2021- NOVEMBER 2024
  • TABLE 460 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: EXPANSIONS, JANUARY 2021- NOVEMBER 2024
  • TABLE 461 CEVA SANTE ANIMALE: COMPANY OVERVIEW
  • TABLE 462 CEVA SANTE ANIMALE: PRODUCTS OFFERED
  • TABLE 463 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 464 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 465 ZOETIS SERVICES LLC: JANUARY 2021-NOVEMBER 2024
  • TABLE 466 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 467 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
  • TABLE 468 VIRBAC: COMPANY OVERVIEW
  • TABLE 469 VIRBAC: PRODUCTS OFFERED
  • TABLE 470 VIRBAC: DEALS, JANUARY 2021- NOVEMBER 2024
  • TABLE 471 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY OVERVIEW
  • TABLE 472 PHIBRO ANIMAL HEALTH CORPORATION: PRODUCTS OFFERED
  • TABLE 473 PHIBRO ANIMAL HEALTH CORPORATION: DEALS, JANUARY 2021- NOVEMBER 2024
  • TABLE 474 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW
  • TABLE 475 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED
  • TABLE 476 HESTER BIOSCIENCES LIMITED: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 477 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY OVERVIEW
  • TABLE 478 MEIJI ANIMAL HEALTH CO., LTD.: PRODUCTS OFFERED
  • TABLE 479 VENKY'S INDIA: COMPANY OVERVIEW
  • TABLE 480 VENKY'S INDIA: PRODUCTS OFFERED
  • TABLE 481 BIMEDA CORPORATE: COMPANY OVERVIEW
  • TABLE 482 BIMEDA CORPORATE: PRODUCTS OFFERED
  • TABLE 483 CALIER: COMPANY OVERVIEW
  • TABLE 484 CALIER: PRODUCTS OFFERED
  • TABLE 485 HIPRA: COMPANY OVERVIEW
  • TABLE 486 HIPRA: PRODUCTS OFFERED
  • TABLE 487 VETANCO: COMPANY OVERVIEW
  • TABLE 488 VETANCO: PRODUCTS OFFERED
  • TABLE 489 VAXXINOVA INTERNATIONAL BV: COMPANY OVERVIEW
  • TABLE 490 VAXXINOVA INTERNATIONAL BV: PRODUCTS OFFERED
  • TABLE 491 BIOVAC GROUP: COMPANY OVERVIEW
  • TABLE 492 BIOVAC GROUP: PRODUCTS OFFERED
  • TABLE 493 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 494 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED
  • TABLE 495 O.L.KAR.-AGROZOOVET-SERVICE: COMPANY OVERVIEW
  • TABLE 496 O.L.KAR.-AGROZOOVET-SERVICE: PRODUCTS OFFERED
  • TABLE 497 INDOVAX: COMPANY OVERVIEW
  • TABLE 498 INDOVAX: PRODUCTS OFFERED
  • TABLE 499 AVIMEX: COMPANY OVERVIEW
  • TABLE 500 AVIMEX: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 MARKET & REGIONAL SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MERCK ANIMAL HEALTH (2023)
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: POULTRY PHARMACEUTICALS MARKET (2023)
  • FIGURE 10 MARKET SIZE ESTIMATION: DEMAND ANALYSIS
  • FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2023-2029)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 POULTRY PHARMACEUTICALS MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 POULTRY PHARMACEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 POULTRY PHARMACEUTICALS MARKET, BY DISEASE INDICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 POULTRY PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF POULTRY PHARMACEUTICALS MARKET
  • FIGURE 19 INCREASING POULTRY CONSUMPTION TO PROPEL MARKET
  • FIGURE 20 VACCINES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 22 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 POULTRY PHARMACEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE
  • FIGURE 26 POULTRY PHARMACEUTICALS MARKET SUPPLY CHAIN ANALYSIS
  • FIGURE 27 POULTRY PHARMACEUTICALS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2014-SEPTEMBER 2024)
  • FIGURE 29 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR POULTRY PHARMACEUTICALS (JANUARY 2014-SEPTEMBER 2024)
  • FIGURE 30 TOP APPLICANT JURISDICTIONS FOR POULTRY PHARMACEUTICAL PATENTS (JANUARY 2014-SEPTEMBER 2024)
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • FIGURE 32 KEY BUYING CRITERIA FOR DRUGS, VACCINES, AND FEED ADDITIVES
  • FIGURE 33 POULTRY PHARMACEUTICALS MARKET: END-USER EXPECTATIONS
  • FIGURE 34 POULTRY PHARMACEUTICALS MARKET: ECOSYSTEM MARKET MAP
  • FIGURE 35 ADJACENT MARKETS OF POULTRY PHARMACEUTICALS MARKET
  • FIGURE 36 INVESTMENT/VENTURE CAPITAL SCENARIO IN POULTRY PHARMACEUTICALS MARKET, 2019-2022
  • FIGURE 37 POULTRY PHARMACEUTICALS MARKET: GEOGRAPHIC SNAPSHOT (2024-2029)
  • FIGURE 38 NORTH AMERICA: POULTRY PHARMACEUTICALS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: POULTRY PHARMACEUTICALS MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN POULTRY PHARMACEUTICALS MARKET (2019-2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY PHARMACEUTICALS MARKET (2023)
  • FIGURE 42 POULTRY PHARMACEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 POULTRY PHARMACEUTICALS MARKET: COMPANY FOOTPRINT
  • FIGURE 44 POULTRY PHARMACEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 POULTRY PHARMACEUTICALS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 MERCK & CO., INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 49 ELANCO: COMPANY SNAPSHOT (2023)
  • FIGURE 50 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2023)
  • FIGURE 52 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 53 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 55 MEIJI ANIMAL HEALTH CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 VENKY'S INDIA: COMPANY SNAPSHOT (2023)